56
Views
5
CrossRef citations to date
0
Altmetric
Preliminary Study

Fluctuating plasma levels of the active moiety of risperidone is related to occurrence of extrapyramidal symptoms

, , , , , & show all
Pages 21-24 | Received 10 Apr 2008, Published online: 12 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ofer Agid, George Foussias & Gary Remington. (2010) Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention. Expert Opinion on Pharmacotherapy 11:14, pages 2301-2317.
Read now

Articles from other publishers (4)

Reiji YOSHIMURA, Hikaru HORI, Asuka KATSUKI & Kiyokazu ATAKE. (2016) Marked Improvement of Meige Syndrome in a Japanese Male Patient with Schizophrenia After Switching from Risperidone to Paliperidone: A Case Report. Journal of UOEH 38:3, pages 233-236.
Crossref
Hidenobu Suzuki, Keishi Gen, Masahiro Otomo, Yuichi Inoue, Hiroyuki Hibino, Ayako Mikami, Hideo Matsumoto & Katsunaka Mikami. (2014) Relationship between the plasma concentration of paliperidone and the clinical and drug-induced extrapyramidal symptoms in elderly patients with schizophrenia. Human Psychopharmacology: Clinical and Experimental 29:3, pages 244-250.
Crossref
Yit-Lung Khung, Wei Li Lee, Kit Leong Chui, Yayuan Liu, Ming Pin Lim, Charlotte Liwen Huang & Say Chye Joachim Loo. (2012) Microencapsulation of Dye- and Drug-Loaded Particles for Imaging and Controlled Release of Multiple Drugs. Advanced Healthcare Materials 1:2, pages 159-163.
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.